欧美日本亚洲国产不卡5岁_欧美激情综合色综合_猫咪av永久网址www大全_免费看无码午夜福利片_亚洲男人的天堂一区二区中文字幕_迈巴赫送考少年发声_无码?V片在线观看免费_日本一区午夜爱爱_亚洲欧美高清在线_95午夜精品影院在线观看

API R&D Platform

High-end system research laboratory

Drug analysis and development platform

Enzyme biocatalysis Technology platform

Marketing Authorization Holder(MAH)

  • API R&D Platform

    Teamwork, Ability

    API R&D Department of Brightgem Bio-tech has an experienced research management team and a well-equipped research and development laboratory, which can provide a complete set of process research services from process design, pilot route development, medium-scale, process optimization to commercial production, and complete the synthesis research of small molecular compounds from milligram to kilogram.

  • High-end system research laboratory

    Advanced, High-end

    We are committed to the research and development and production of sustained-release preparation products as the core, and continue to develop high barriers and difficult to copy preparation varieties, to meet the domestic and foreign market demand.

  • Enzyme biocatalysis Technology platform

    Environment protecting, High efficiency

    We have a whole system of enzyme-catalyzed reactions
    Batch screening process suitable enzymes, design enzyme reaction path, optimize the process
    It can be used for process amplification and commercial batch production from gram to kilogram.

  • Drug analysis and development platform

    Professional, compliance

    Our analytical research and development team can provide a full range of analysis and testing support for THE R&D and production of API and preparation, from analysis method development, method validation, analysis method transfer to API or preparation testing for the whole process, and in strict accordance with relevant regulations and requirements, to ensure high quality service.

  • Marketing Authorization Holder(MAH)

    International, pioneer, practitioner

    We established MAH certification platform in accordance with the latest national requirements, and established a complete quality management, pharmacovigilance, risk management system. The first drug that passed the consistency evaluation was successfully operated on the platform, striving to become the MAH demonstration platform.

Copyright(C)2020,Hangzhou Huang Sen Biological Technology Co., Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle